About Investors Technology Products News Contact H. Pylori Reveal HP detects HP antibodies in serum, plasma or whole blood produced in response to HP infection. This test delivers highly accurate results to patients and their healthcare providers within minutes, enabling the right treatment to begin immediately. Reveal HP detects HP antibodies in serum, plasma or whole blood produced in response to HP infection. The presence of HP antibodies is indicative of exposure to the agent, and assists in the confirmation of HP infection with additional tests. Helicobacter pylori (HP) is a bacterial agent associated with peptic ulcer disease and cancers of the human gastrointestinal tract. HP infections, prevalent throughout the world, are treatable with antibiotics; however untreated HP infections can lead to stomach cancer. Reveal HP is available in three product formats as follows: Point-of-Care: ideally suited to testing at the point of patient care in settings requiring a portable and all-in-one testing solution Cat. No. 815311004148 Qty. 20 tests per box LAB+: this format maximizes testing flexibility for whole blood, serum or plasma specimens Cat. No. 815311004155 Qty. 50 tests per box LAB S/P: for use with serum and plasma specimens in the laboratory and batch testing. Cat. No. 815311004162 Qty. 50 tests per box This product is not cleared by the FDA, and therefore is not available for sale or use in the USA. CONTACT US | LEGAL INFO | NEWS & EVENTS ©2020 MedMira Inc. All Rights Reserved. Follow us on